Del Brutto OH, 2014. Chapter 97–neurocysticercosis. Biller J, Ferro JM, eds. Handbook in Clinical Neurology, Vol. 121. Amsterdam, The Netherlands: Elsevier, 1445–1459.
Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian Y-J, Rainwater E, Dickey M, Reynolds S, Stoner JA, 2010. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.
CDC, 1993. Recommendations of the International Task Force for Disease Eradication. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00025967.htm. Accessed May 14, 2016.
Pawlowski Z, Schultz MG, 1972. Taeniasis and cysticercosis (Taenia saginata). Adv Parasitol 10: 269–343.
Garcia HH, Gonzalez AE, Rodriguez S, Gonzalvez G, Llanos-Zavalaga F, Tsang VC, Gilman RH; Grupo de Trabajo en Cisticercosis en Perú, 2010. Epidemiología y control de la cisticercosis en el Perú. Rev Peru Med Exp Salud Publica 27: 592–597.
Garcia HH et al. Cysticercosis Working Group in Peru, 2016. Elimination of Taenia solium transmission in northern Peru. N Engl J Med 374: 2335–2344.
Guezala M-C, Rodriguez S, Zamora H, Garcia HH, Gonzalez AE, Tembo A, Allan JC, Craig PS, 2009. Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis. Am J Trop Med Hyg 81: 433–437.
World Health Organization, 2012. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation: Executive Summary. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/iris/handle/10665/70809.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 658 | 608 | 22 |
Full Text Views | 1089 | 10 | 0 |
PDF Downloads | 149 | 7 | 0 |
Reintroduction of Taenia solium into a region in Peru where it had been eliminated prompted evaluation of the possibility of reintroduction from an urban reservoir of taeniasis. In a cross-sectional study of an adjacent urban area, we found low prevalence of taeniasis (4/1,621; 0.25%), suggesting minimal risk of parasite reintroduction into rural areas through this route.
Financial support: This research was made possible with support from the National Institute of Neurological Disorders and Stroke (NINDS) and the Fogarty International Center (FIC) under the Brain Disorders in the Developing World: Research across the Lifespan program (grant R01NS080645).
Authors’ addresses: Lauralee Fernandez, Ian Pray, Angela Spencer, and Seth E. O’Neal, Oregon Health & Science University, Portland, OR, and Portland State University, Portland, OR, E-mails: fernanla@ohsu.edu, pray@ohsu.edu, angela.g.spencer@pdx.edu, and oneals@ohsu.edu. Ricardo Gamboa, Percy Vilchez, Ruth Atto, Claudio Muro, and Hector H. Garcia, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mails: rgamboa@peruresearch.org, pvilchez@peruresearch.org, ratto@peruresearch.org, Claudio.muro@peruresearch.org, and hgarcia@jhsph.edu. Michelle Beam and Brian Garvey, Oregon Health & Science University, Portland, OR, E-mails: beam@ohsu.edu and garveyb@ohsu.edu. Luz Maria Moyano, Centro de Salud Global, Tumbes, Peru, E-mail: luzmariamoyano@gmail.com.
Del Brutto OH, 2014. Chapter 97–neurocysticercosis. Biller J, Ferro JM, eds. Handbook in Clinical Neurology, Vol. 121. Amsterdam, The Netherlands: Elsevier, 1445–1459.
Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian Y-J, Rainwater E, Dickey M, Reynolds S, Stoner JA, 2010. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.
CDC, 1993. Recommendations of the International Task Force for Disease Eradication. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00025967.htm. Accessed May 14, 2016.
Pawlowski Z, Schultz MG, 1972. Taeniasis and cysticercosis (Taenia saginata). Adv Parasitol 10: 269–343.
Garcia HH, Gonzalez AE, Rodriguez S, Gonzalvez G, Llanos-Zavalaga F, Tsang VC, Gilman RH; Grupo de Trabajo en Cisticercosis en Perú, 2010. Epidemiología y control de la cisticercosis en el Perú. Rev Peru Med Exp Salud Publica 27: 592–597.
Garcia HH et al. Cysticercosis Working Group in Peru, 2016. Elimination of Taenia solium transmission in northern Peru. N Engl J Med 374: 2335–2344.
Guezala M-C, Rodriguez S, Zamora H, Garcia HH, Gonzalez AE, Tembo A, Allan JC, Craig PS, 2009. Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis. Am J Trop Med Hyg 81: 433–437.
World Health Organization, 2012. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation: Executive Summary. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/iris/handle/10665/70809.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 658 | 608 | 22 |
Full Text Views | 1089 | 10 | 0 |
PDF Downloads | 149 | 7 | 0 |